Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience
- PMID: 35314656
- PMCID: PMC8938784
- DOI: 10.3390/idr14020026
Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience
Abstract
Background: Nowadays, infective endocarditis (IE) is still burdened by a high mortality. In the absence of an adequate prognostic stratification system, it is important to assess new predictors of poor outcomes. The aim of our study is to evaluate which factors were associated with higher mortality in IE patients. Methods: A retrospective cohort study enrolled patients with an IE diagnosis at the Infectious Diseases Clinic of the University ‘G. D’Annunzio’, Chieti, Italy from January 2013 to December 2019. For each patient, demographic, anamnestic and clinical information, embolic phenomena, laboratory and microbiologic data, treatment, and outcomes were collected and analyzed. A correlation analysis was performed. Results: Sixty-eight patients with EI were studied; among them, the mortality was 17.6%, 20.6%, and 23.5%, intra-hospital, at 1 month from discharge and at 6 months from discharge, respectively. Mortality was significantly correlated with age, estimated glomerular filtration rate, and procalcitonin values when considering either basal values (r = 0.266, p = 0.029), or values at 48−72 h from the start of an antibiotic therapy (r = 0.222; p < 0.05), cerebral embolization for 6-month mortality (r = 0.284; p = 0.019), and inadequate antibiotic therapy (r = 0.232, p < 0.05). Conclusions: Procalcitonin values, at EI diagnosis and at 48−72 h after starting antibiotics, are prognostic factors useful for stratifying patient risk, and for setting up a personalized treatment. Of note, cerebral embolization and an inappropriate empirical treatment were associated with a higher mortality in the short- and long-term.
Keywords: embolization; in-hospital mortality; infective endocarditis; procalcitonin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Comparison of outcome between blood culture positive and negative infective endocarditis patients undergoing cardiac surgery.J Cardiothorac Surg. 2021 May 27;16(1):147. doi: 10.1186/s13019-021-01532-9. J Cardiothorac Surg. 2021. PMID: 34044847 Free PMC article.
-
Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.JAMA Netw Open. 2020 Oct 1;3(10):e2016228. doi: 10.1001/jamanetworkopen.2020.16228. JAMA Netw Open. 2020. PMID: 33052402 Free PMC article.
-
Hematologic Parameters as Predictors of Long-Term Mortality in Infective Endocarditis Patients.Med Sci Monit. 2023 Dec 28;29:e941758. doi: 10.12659/MSM.941758. Med Sci Monit. 2023. PMID: 38151856 Free PMC article.
-
Infective endocarditis in patients with rheumatic heart disease: a single-centre retrospective comparative study.N Z Med J. 2022 Feb 25;135(1550):62-73. N Z Med J. 2022. PMID: 35728153 Review.
-
Incidence and mortality of infective endocarditis in the last decade: a single center study.J Cardiovasc Med (Hagerstown). 2023 Feb 1;24(2):105-112. doi: 10.2459/JCM.0000000000001410. Epub 2022 Dec 22. J Cardiovasc Med (Hagerstown). 2023. PMID: 36574285 Review.
Cited by
-
Outcomes of infective endocarditis in patients with end-stage renal disease in Spain: a population-based study.BMC Infect Dis. 2025 Apr 23;25(1):591. doi: 10.1186/s12879-025-10978-4. BMC Infect Dis. 2025. PMID: 40269735 Free PMC article.
-
Splenic Embolism in Infective Endocarditis: A Systematic Review of the Literature with an Emphasis on Radiological and Histopathological Diagnoses.Trop Med Infect Dis. 2024 Apr 12;9(4):83. doi: 10.3390/tropicalmed9040083. Trop Med Infect Dis. 2024. PMID: 38668544 Free PMC article. Review.
References
-
- Bennett J., Dolin R., Blaser M. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Elsevier; Amsterdam, The Netherlands: 2019.
-
- Yeager S.D., Oliver J.E., Shorman M.A., Wright L.R., Veve M.P. Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections. Int. J. Antimicrob. Agents. 2021;57:106329. doi: 10.1016/j.ijantimicag.2021.106329. - DOI - PubMed
LinkOut - more resources
Full Text Sources